20 May 2022: Clinical Research
Importance of Influenza Anti-Hemagglutinin Antibodies During the SARS-CoV-2 Pandemic in the 2019/2020 Epidemic Season in Poland
Lidia B. Brydak 1ADEFG , Karol Szymański 1BF , Katarzyna Kondratiuk 1BF , Anna Poznańska 2CDE , Adam Kolondra 1B , Ewelina Hallmann 1BDEF*DOI: 10.12659/MSM.936495
Med Sci Monit 2022; 28:e936495
Table 4 Comparison of parameters of 300 people aged 15–64 years from the 2019/2020 serological review (3 combined age groups) with those of COVID convalescents (934 people).
| 2019/2020 (age 15–64) | COVID convalescents | p | |||
|---|---|---|---|---|---|
| N | Value | N | Value | ||
| Response rate | 300 | 32.7 [27.4–38.0]% | 934 | 37.8 [34.7–40.9]% | NS |
| GMT | 98 | 69.0 [58.4–79.5] | 353 | 99.7 [90.6–108.7] | |
| Response rate | 300 | 60.7 [55.1–66.2]% | 934 | 63.8 [60.7–66.9]% | NS |
| GMT | 182 | 89.0 [81.0–97.0] | 596 | 98.2 [92.7–103.6] | NS |
| Response rate | 300 | 4.3 [2.0–6.6]% | 934 | 32.3 [29.3–35.3]% | |
| GMT | 13 | 52.2 [38.4–66.1] | 302 | 80.7 [74.1–87.3] | |
| Response rate | 300 | 31.7 [26.4–36.9]% | 934 | 61.6 [58.4–64.7]% | |
| GMT | 95 | 76.0 [66.5–85.5] | 575 | 76.4 [72.1–80.7] | NS |